Mesa Laboratories (MLAB) Stock Statistics & Valuation Metrics

Mesa Laboratories has a market cap or net worth of $589.28M. The enterprise value is $536.71M.

Mesa Laboratories has 5,524,813 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesa Laboratories’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 2.42%.

The current PE Ratio of Mesa Laboratories is 86.2. Mesa Laboratories’s PEG ratio is -0.17.

In the last 12 months, Mesa Laboratories had revenue of 249.13M and earned 6.71M in profits. Earnings per share was 1.22.

In the last 12 months, operating cash flow was 41.53M and capital expenditures -3.84M, giving a free cash flow of 37.69M billion.

Mesa Laboratories pays an annual dividend of $0.16, resulting in a dividend yield of 0.79%

Mesa Laboratories upcoming earnings date is Jul 30, 2026, TBA (Confirmed).

Mesa Laboratories as a current ratio of 1.72, with Debt / Equity ratio of 48.39%

In the past 12 months, Mesa Laboratories has paid 5.30M in taxes.

Mesa Laboratories EV to EBITDA ratio is 11.02, with an EV/FCF ratio of 0.00.

Mesa Laboratories has $28.98M in cash and marketable securities with $103.41M in debt, giving a net cash position of -$74.43M billion.

Gross margin is 63.53%, with operating margin of 7.43%, and net profit margin of 2.69%.

The average price target for Mesa Laboratories is $104.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy